无码人妻21p,日本不卡VS一区二区,按摩按到少妇出水,又色又爽又黄的视频女女

篩選
全部清除
發(fā)表時間
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
產(chǎn)品類型
Luc陰性對照慢病毒
研究領(lǐng)域
腫瘤
神經(jīng)
代謝
內(nèi)臟
mRNA疫苗
膀胱癌
細(xì)胞癌
肝臟
前列腺癌
細(xì)胞轉(zhuǎn)錄
乳腺癌
視網(wǎng)膜細(xì)胞癌
直腸癌
炎癥
阿茲海默癥
卵巢癌
甲狀腺癌
宮頸癌
急性髓系白血病
高血糖
糖尿病
冠狀病毒
胃癌
其他
結(jié)直腸癌
頭頸癌
腎炎
肝癌
肺癌
肺腺癌
鼻咽癌
胰腺癌
骨癌
減肥
哮喘
免疫
腎癌
當(dāng)前位置:資源中心 > 客戶文獻(xiàn)
客戶文獻(xiàn)
共 328 內(nèi)容
IF=17.521,Advanced Science,上海市新藥設(shè)計重點實驗室,過表達(dá)慢病毒
Multi‐Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation
IF=10.334,Pharmacological Research,中國科學(xué)院上海藥物研究所,過表達(dá)AAV
New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice
IF=11.6,Theranostics,中國藥科大學(xué)中藥學(xué)院,過表達(dá)質(zhì)粒,sgRNA質(zhì)粒
The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists
IF=38.102,Signal Transduction and Targeted Therapy,廣西國際納米抗體研究中心,過表達(dá)質(zhì)粒
Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
IF=31.791,Gut,復(fù)旦大學(xué),siRNA合成
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism
IF=12.657,Journal of Experimental & Clinical Cancer Research,廣州醫(yī)科大學(xué),AP-1-luc報告基因質(zhì)粒
The miR-1185-2-3p—GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1
IF=12.416,Basic Research in Cardiology,中國藥科大學(xué)藥學(xué)院,過表達(dá)AAV
Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1
IF=41.444,Molecular Cancer,中山大學(xué)第一附屬醫(yī)院,cirCRNA過表達(dá)質(zhì)粒
Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis
IF=14.903,Acta Pharmaceutica Sinica B,中國藥科大學(xué)天然藥物國家重點實驗室,嘌呤霉素
A novel PGAM5 inhibitor LFHP-1c protects blood–brain barrier integrity in ischemic stroke
IF=10.183,Molecular Therapy-Nucleic Acids,南京醫(yī)科大學(xué)第一附屬醫(yī)院,過表達(dá)質(zhì)粒、siRNA合成
Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway
首頁 25 26 27 28 29 末頁
共 33 頁
跳轉(zhuǎn)
當(dāng)前位置:資源中心 > 客戶文獻(xiàn)

客戶文獻(xiàn)
共 328 內(nèi)容
IF=17.521,Advanced Science,上海市新藥設(shè)計重點實驗室,過表達(dá)慢病毒
Multi‐Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation
IF=10.334,Pharmacological Research,中國科學(xué)院上海藥物研究所,過表達(dá)AAV
New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice
IF=11.6,Theranostics,中國藥科大學(xué)中藥學(xué)院,過表達(dá)質(zhì)粒,sgRNA質(zhì)粒
The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists
IF=38.102,Signal Transduction and Targeted Therapy,廣西國際納米抗體研究中心,過表達(dá)質(zhì)粒
Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy
IF=31.791,Gut,復(fù)旦大學(xué),siRNA合成
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism
IF=12.657,Journal of Experimental & Clinical Cancer Research,廣州醫(yī)科大學(xué),AP-1-luc報告基因質(zhì)粒
The miR-1185-2-3p—GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1
IF=12.416,Basic Research in Cardiology,中國藥科大學(xué)藥學(xué)院,過表達(dá)AAV
Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1
IF=41.444,Molecular Cancer,中山大學(xué)第一附屬醫(yī)院,cirCRNA過表達(dá)質(zhì)粒
Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis
IF=14.903,Acta Pharmaceutica Sinica B,中國藥科大學(xué)天然藥物國家重點實驗室,嘌呤霉素
A novel PGAM5 inhibitor LFHP-1c protects blood–brain barrier integrity in ischemic stroke
IF=10.183,Molecular Therapy-Nucleic Acids,南京醫(yī)科大學(xué)第一附屬醫(yī)院,過表達(dá)質(zhì)粒、siRNA合成
Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway
MORE
篩選
全部清除
發(fā)表時間
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
產(chǎn)品類型
Luc陰性對照慢病毒
研究領(lǐng)域
腫瘤
神經(jīng)
代謝
內(nèi)臟
mRNA疫苗
膀胱癌
細(xì)胞癌
肝臟
前列腺癌
細(xì)胞轉(zhuǎn)錄
乳腺癌
視網(wǎng)膜細(xì)胞癌
直腸癌
炎癥
阿茲海默癥
卵巢癌
甲狀腺癌
宮頸癌
急性髓系白血病
高血糖
糖尿病
冠狀病毒
胃癌
其他
結(jié)直腸癌
頭頸癌
腎炎
肝癌
肺癌
肺腺癌
鼻咽癌
胰腺癌
骨癌
減肥
哮喘
免疫
腎癌
重置
確定
Tel: 400-627-9288
留言咨詢
重置
提交
客服
微信
電話
留言
留言咨詢
重置
提交